Serum copper and calcium as potential biomarkers after spinal cord injury: experimental and translational evidence

Technical Summary: Serum Copper and Calcium as Potential Biomarkers After Spinal Cord Injury

Problem Statement
Traumatic spinal cord injury (SCI) initiates a complex secondary injury cascade involving oxidative stress, neuroinflammation, and progressive tissue damage. Despite advances in acute management, functional recovery remains highly variable, and reliable blood-based biomarkers reflecting these secondary processes are limited. While trace elements like copper (Cu) and calcium (Ca) are known to play central roles in cellular metabolism, redox regulation, and immune signaling, their systemic temporal dynamics following SCI and their potential as prognostic biomarkers remain insufficiently characterized. Furthermore, the influence of immunomodulatory interventions, specifically Interleukin-4 (IL-4), on the homeostasis of these elements is unknown.

Methodology
The study employed a dual approach combining a controlled experimental model in rats with a translational analysis of a clinical human cohort.

• Experimental Model: 120 female Wistar rats underwent thoracic clip-compression SCI or sham surgery. Animals were randomized to receive either systemic recombinant rat IL-4 (0.5 µg/kg intraperitoneally every 12 hours for 7 days) or a vehicle control. Serum samples were collected at 1, 3, 7, 14, and 28 days post-injury (dpi).
• Quantification: Serum copper and calcium concentrations were measured using total reflection X-ray fluorescence (TXRF) spectroscopy. Systemic inflammatory responses were assessed via multiplex bead-based immunoassays (LEGENDplex™) for 19 cytokines.
• Functional Assessment: Neurological recovery was evaluated at 28 dpi using the Basso, Beattie, and Bresnahan (BBB) locomotor rating scale.
• Clinical Cohort: Serum samples from a prospectively maintained institutional SCI registry (collected 2011–study period) were analyzed retrospectively. Patients were stratified into "favorable" (improvement of ≥1 AIS grade at 12 weeks) and "non-favorable" outcome groups. Copper levels were measured at admission and serially thereafter.
• Statistical Analysis: Data were analyzed using ANOVA with post-hoc testing and Pearson correlation analyses. Associations were adjusted for multiple testing using the Benjamini-Hochberg false discovery rate (FDR) procedure.

Key Results

• Temporal Dynamics of Trace Elements:
  • Copper: SCI induced a distinct early increase in serum copper, peaking at 3 dpi before declining toward baseline by 7–28 dpi.
  • Calcium: In contrast, calcium exhibited a delayed and more complex profile, characterized by an initial reduction followed by a transient peak at 7 dpi.
• Impact of IL-4 Treatment: Systemic IL-4 administration significantly attenuated the acute inflammatory response. In treated rats, the 3-day copper peak was completely suppressed (approx. 50% reduction at 3 dpi), and the characteristic 7-day calcium peak was abolished.
• Correlation with Inflammation: Both copper and calcium concentrations showed significant positive correlations with pro-inflammatory cytokines (e.g., IL-1α, IL-6, TNF-α, KC) and negative correlations with anti-inflammatory cytokines (IL-4, IL-10) during the acute phase. These associations were primarily confined to the early post-injury period.
• Association with Neurological Outcome:
  • Rats: Elevated copper at 3 dpi and elevated calcium at 7 dpi were significantly associated with poorer BBB locomotor scores at 28 dpi. IL-4 treated animals, which had lower trace element levels, demonstrated improved functional recovery.
  • Humans: Patients with non-favorable neurological outcomes exhibited significantly higher serum copper concentrations at 3 dpi compared to those with favorable outcomes. The temporal profile of copper elevation in humans closely mirrored the dynamics observed in the rat model.

Key Contributions

1. Characterization of Trace Element Kinetics: The study provides the first detailed temporal profile of systemic copper and calcium dynamics following experimental SCI, revealing distinct early (copper) and delayed (calcium) peaks.
2. Link to Immunomodulation: It demonstrates that trace element homeostasis is responsive to immunomodulation, as IL-4 treatment significantly reduced the elevation of both elements, linking immune activity directly to systemic mineral regulation.
3. Prognostic Value: The research establishes a correlation between elevated acute-phase serum copper and impaired neurological recovery in both preclinical and clinical settings, suggesting copper's utility as a prognostic biomarker.
4. Translational Consistency: The study validates that the specific temporal dynamics of serum copper observed in rats are reproducible in human SCI patients, addressing a common challenge in translating preclinical findings to clinical practice.

Significance and Claims
The authors conclude that SCI induces characteristic, temporally regulated alterations in serum copper and calcium that are closely associated with systemic inflammation and neurological outcome. The attenuation of these changes by IL-4 supports the hypothesis that trace element homeostasis is integrated into the post-traumatic immune response.

The paper posits that serum copper, in particular, represents a promising, accessible biomarker candidate for reflecting injury severity and recovery potential. The concordance between experimental and human data suggests that systemic trace element dynamics capture conserved inflammatory mechanisms across species. While the study acknowledges limitations regarding causality and the lack of tissue-level analysis, it argues that these findings support further investigation of trace elements, especially copper, for clinical prognostication and as pharmacodynamic markers for therapeutic monitoring in SCI. The authors emphasize that these results provide a basis for developing biomarker-guided strategies but call for larger prospective clinical studies and mechanistic investigations before clinical implementation.